Ilocaps en es it fr

Ilocaps Brand names, Ilocaps Analogs

Ilocaps Brand Names Mixture

  • No information avaliable

Ilocaps Chemical_Formula


Ilocaps RX_link

No information avaliable

Ilocaps fda sheet

Ilocaps msds (material safety sheet)

Ilocaps Synthesis Reference

No information avaliable

Ilocaps Molecular Weight

167.205 g/mol

Ilocaps Melting Point

96 oC

Ilocaps H2O Solubility

2500 mg/L

Ilocaps State


Ilocaps LogP


Ilocaps Dosage Forms

No information avaliable

Ilocaps Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Ilocaps Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Ilocaps Absorption

Rapidly absorbed following oral administration.

Ilocaps side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Ilocaps Patient Information

Ilocaps Organisms Affected

Humans and other mammals